ArticleFrontiers in pharmacology2020

Repositioning an Immunomodulatory Drug Vidofludimus as a Farnesoid X Receptor Modulator With Therapeutic Effects on NAFLD.

Yanlin Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.